Align Technology, Inc. operates in the lucrative medical devices sector, focusing on innovative products like Invisalign and iTero scanners. With strong fundamentals and a diverse global market presence, ALGN presents a promising investment opportunity. However, potential investors should weigh the high price-to-earnings ratio cautiously.
The company exhibits a strong financial posture with outstanding return metrics, offering promising growth potential.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
A review of recent ratings highlights the company's steady performance consistency across key metrics.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-13 | 3 | 4 | 4 | 5 | 3 | 1 | 2 |
| N/A | 0 | 4 | 4 | 5 | 3 | 1 | 2 |
Analysts have set ambitious price targets indicating a strong bullish sentiment towards the stock.
| High | Low | Median | Consensus |
|---|---|---|---|
| $790 | $225 | $300 | $421 |
Analysts exhibit a consensus view of the stock being a strong buy with minimal downside risk.
| Count | Visual | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 24 | |
| Hold | 5 | |
| Sell | 1 | |
| Strong Sell | 0 |
Align Technology, Inc. presents a compelling growth narrative with its innovative product line and strong market footprint. While its fundamentals suggest robust potential, the elevated P/E ratio and mixed historic scores highlight areas for cautious optimism. The company's strategic global approach and analyst backing reinforce its promising outlook, though market volatility remains a consideration.